A significant shift in Canadian drug policy has happened, as the regulators allow the use of psilocybin fungi for therapeutic purposes. Previously, these substances were strictly restricted, but a growing body of research suggests they potentially offer relief for psychological conditions like anxiety. This development represents a key step toward